Sensex and Nifty Trends
The BSE Sensex opened robustly at 78,152.34, gaining 650.22 points (0.84%) in early trade before settling slightly lower but still maintaining a solid gain of 527.33 points (0.68%) by mid-session. The Nifty benchmark mirrored this strength, supported by broad-based buying in large-cap stocks. Notably, the Sensex is trading above its 50-day moving average (DMA), signalling short-term bullish momentum, although the 50DMA remains below the 200DMA, indicating that the longer-term trend has yet to fully confirm an uptrend.
Sectoral Performance: IT and Pharma Shine
Out of 38 sectors tracked, 25 advanced while 13 declined, underscoring a broadly positive market breadth. The Nifty IT sector emerged as the top gainer, surging 2.49%, driven by strong buying interest in technology stocks. The pharmaceutical sector also impressed, with the Nifty Pharma and S&P BSE Healthcare indices hitting new 52-week highs, reflecting robust investor confidence in healthcare amid ongoing global health concerns and steady earnings outlooks.
Conversely, the BSE Capital Goods sector was the worst performer, falling 2.17%, weighed down by profit-taking and subdued demand outlooks. This divergence highlights the selective nature of the rally, with investors favouring defensive and growth-oriented sectors over cyclical ones.
Market Breadth and Capitalisation Trends
The advance-decline ratio across the BSE500 stood at a healthy 1.21x, with 272 stocks advancing against 224 declining. Large caps led the charge, with the BSE100 index rising 0.53%, while small caps edged up 0.20%. Midcaps, however, slipped marginally by 0.10%, indicating a cautious stance among investors towards mid-sized companies amid mixed earnings prospects.
Top Gainers and Losers Across Market Caps
Among the top performers on the BSE500, Zensar Technologies led with a remarkable 10.25% gain, followed by eClerx Services at 7.84% and Sumitomo Chemical at 7.76%. These stocks benefited from sector-specific tailwinds and positive corporate developments.
On the downside, GE Vernova Transmission & Distribution plunged 10.15%, Hitachi Energy declined 8.92%, and CG Power & Industrial fell 7.25%, reflecting profit booking and sectoral headwinds in capital goods and industrials.
Focusing on market capitalisation segments, HCL Technologies was the top large-cap gainer, surging 6.65%, while PB Fintech was the largest large-cap laggard, dropping 5.17%. In the midcap space, Aurobindo Pharma gained 4.69%, contrasting with GE Vernova T&D’s sharp 10.15% fall. Among small caps, Zensar Tech’s 10.25% rally stood out, whereas Apar Industries declined 6.71%.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Foreign Institutional and Domestic Investor Activity
Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) continued to play a pivotal role in shaping market direction. While detailed net inflow/outflow figures were not disclosed today, the overall positive market tone suggests sustained buying interest from DIIs, which often provide stability during volatile sessions. FIIs have been selectively accumulating quality large caps, particularly in IT and pharma, aligning with global trends favouring technology and healthcare sectors amid geopolitical uncertainties.
Global Cues and Their Impact
Global markets exhibited mixed signals today, with US indices showing modest gains while European markets remained subdued amid concerns over inflation and monetary policy tightening. Crude oil prices stabilised after recent volatility, providing some relief to energy-importing economies like India. These global factors contributed to cautious optimism among Indian investors, who balanced domestic earnings prospects with external uncertainties.
Technical Outlook and Moving Averages
Technically, the Sensex trading above its 50DMA is a positive short-term indicator, suggesting momentum is building. However, the 50DMA still lagging below the 200DMA indicates that the market is in a consolidation phase and has not yet confirmed a sustained uptrend. Investors will be closely watching upcoming corporate earnings and global developments to gauge the next directional move.
Upcoming Corporate Results to Watch
Market participants are gearing up for key earnings announcements next week, which could provide fresh impetus or caution. Tata Consultancy Services (TCS) is scheduled to report on 9 July 2026, followed by L&T Finance Ltd on 10 July and LTM on 11 July. These results will be closely analysed for revenue growth, margin trends, and outlook commentary, especially in the context of global economic challenges and domestic demand recovery.
Curious about from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Summary and Investor Takeaways
In summary, the Indian equity market demonstrated resilience on 3 July 2026, with large caps and defensive sectors such as IT and pharma leading the advance. The mixed performance in mid and small caps, along with sectoral divergences, suggests investors remain selective, favouring quality and growth-oriented stocks amid ongoing global uncertainties.
Market breadth was positive, supported by a favourable advance-decline ratio and steady institutional participation. However, caution is warranted given the technical setup and upcoming earnings season, which could introduce volatility depending on corporate performance and macroeconomic developments.
Investors should monitor the evolving global environment, domestic policy cues, and sector-specific trends to navigate the market effectively. The current environment favours a balanced approach, combining exposure to resilient large caps with selective mid and small-cap opportunities that demonstrate strong fundamentals and growth potential.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
